Preclinical Characterisation of a Novel 68Ga/177Lu-Labeled Fibroblast Activation Protein (FAP) Targeted Peptide Binder for Cancer Imaging & Therapy

Time: 3:00 pm
day: Conference Day 2


• NT6020 is a potent and specific novel peptide binder to FAP.

• 177Lu-NT6020 demonstrates efficient and continued tumour uptake with fast renal clearance, and minimal normal tissue uptake.

• 177Lu-NT6020 significantly inhibits tumour growth in FAP-expressing HEK293 xenograft model.